Stories > Anima Biotech's Promising Lung Fibrosis Candidate

Anima Biotech's Promising Lung Fibrosis Candidate

4D Molecular Therapeutics Raises $300 Mi...

89bio to Present pegozafermin for NASH a...

ACTICOR BIOTECH Delays Key Documents

ABIONYX Pharma Files 2023 Document

AEON Biopharma Advances Migraine Treatme...

AEON Biopharma Advances Migraine Treatme...